Authors:
OXLEY J
BREWSTER S
ABBOTT C
TRIVELLA M
GILLATT D
Citation: J. Oxley et al., P53, BCL-2, E-CADHERIN AND CD44 EXPRESSION AS PREDICTORS OF TREATMENTFAILURE AFTER RADICAL PROSTATECTOMY, Journal of pathology, 186, 1998, pp. 34-34
Authors:
DELAROSETTE JJMCH
MUSCHTER R
LOPEZ MA
GILLATT D
Citation: Jjmch. Delarosette et al., INTERSTITIAL LASER COAGULATION IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA USING A DIODE-LASER SYSTEM WITH TEMPERATURE FEEDBACK, British Journal of Urology, 80(3), 1997, pp. 433-438
Authors:
MUSCHTER R
DELAROSETTE JJMCH
WHITFIELD H
PELLERIN JP
MADERSBACHER S
GILLATT D
Citation: R. Muschter et al., INITIAL HUMAN CLINICAL-EXPERIENCE WITH DIODE-LASER INTERSTITIAL TREATMENT OF BENIGN PROSTATIC HYPERPLASIA, Urology, 48(2), 1996, pp. 223-228
Citation: Jm. Reynard et al., PROSTATE-SPECIFIC ANTIGEN AND PROGNOSIS IN PATIENTS WITH METASTATIC PROSTATE-CANCER - A MULTIVARIABLE ANALYSIS OF PROSTATE-CANCER MORTALITY, British Journal of Urology, 75(4), 1995, pp. 507-515
Citation: D. Gillatt et Jm. Reynard, WHAT IS THE NORMAL RANGE FOR PROSTATE-SPECIFIC ANTIGEN - USE OF A RECEIVER OPERATING CHARACTERISTIC CURVE TO EVALUATE A SERUM MARKER, British Journal of Urology, 75(3), 1995, pp. 341-346